Skip main navigation

The Future for Vaccines and Antimicrobial Resistance

Discussion on the future of vaccine development
© BSAC
In a climate of limited resources it is important to prioritise research priorities, policy focus and investment decisions on vaccines that can have the greatest impact on health.
In a recent assessment of the potential of vaccines to tackle AMR, the Wellcome Trust examined WHO priority pathogens for AMR and advised how best to ensure effective vaccines are available in the future (see figure below). In some circumstances this is likely to be achieved by simply increasing uptake of licensed, effective vaccines, such as Streptococcus pneumoniae. In the case of other bacteria it involves funding to advance research and development (R&D) of promising vaccine candidates.
vaccine health impact vs probability of R&D success Image from https://vaccinesforamr.org/read-the-report/
(Click to expand)
Please visit the WHO link provided under Additional Resources to know more about vaccine research and development.
© BSAC
This article is from the free online

The Role of Vaccines in Preventing Infectious Diseases and Antimicrobial Resistance

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education